{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:24:40Z","timestamp":1790061880008,"version":"4.0.1"},"reference-count":38,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T00:00:00Z","timestamp":1432166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Chagas disease results from infection by the protozoan parasite <jats:italic>Trypanosoma cruzi<\/jats:italic> and is endemic in Latin America. <jats:italic>T cruzi<\/jats:italic> is most commonly transmitted through the feces of an infected triatomine, but can also be congenital, via contaminated blood transfusion or through direct oral contact. In the acute phase, the disease can cause cardiac derangements such as myocarditis, conduction system abnormalities, and\/or pericarditis. If left untreated, the disease advances to the chronic phase. Up to one\u2010half of these patients will develop a cardiomyopathy, which can lead to cardiac failure and\/or ventricular arrhythmias, both of which are major causes of mortality. Diagnosis is confirmed by serologic testing for specific immunoglobulin G antibodies. Initial treatment consists of the antiparasitic agents benznidazole and nifurtimox. The treatment of Chagas cardiac disease comprises standard medical therapy for heart failure and amiodarone for ventricular arrhythmias, with consideration for implantable cardioverter\u2010defibrillator. Chagas disease causes the highest infectious burden of any parasitic disease in the Western Hemisphere, and increased awareness of this disease is essential to improve diagnosis, enhance management, and reduce spread.<\/jats:p>","DOI":"10.1002\/clc.22421","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T11:27:28Z","timestamp":1432207648000},"page":"565-569","source":"Crossref","is-referenced-by-count":80,"title":["The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease"],"prefix":"10.1002","volume":"38","author":[{"given":"Lindsey H.","family":"Malik","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine University of California Davis Medical Center  Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan D.","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine University of California Davis Medical Center  Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra A.","family":"Amsterdam","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine University of California Davis Medical Center  Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02761991000300002"},{"key":"e_1_2_10_3_1","unstructured":"Centers for Disease Control and Prevention. Parasites\u2014American trypanosomiasis (also known as Chagas Disease).http:\/\/www.cdc.gov\/parasites\/Chagas. Accessed May 1 2014."},{"key":"e_1_2_10_4_1","article-title":"Chagasic cardiomyopathy is associated with increased morbidity and mortality compared with nonischemic cardiomyopathy among Latin American immigrants in Los Angeles","volume":"126","author":"Traina M","year":"2012","journal-title":"Circulation."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/605091"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762007005000093"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.2741\/948"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir956"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60061-X"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.57.328"},{"key":"e_1_2_10_11_1","first-page":"287","article-title":"Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy","volume":"7","author":"Rossi M.","year":"1991","journal-title":"Can J Cardiol."},{"key":"e_1_2_10_12_1","first-page":"378","article-title":"Electrocardiography repolarization abnormalities are characteristic signs of acute Chagasic cardiomyopathy","volume":"53","author":"Alvarado\u2010Tapias E","year":"2012","journal-title":"Invest Clin."},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2012.109"},{"key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4269\/ajtmh.2007.77.495","article-title":"Electrocardiographic characteristics in a population with high rates of seropositivity for Trypanosoma cruzi infection","volume":"77","author":"Williams\u2010Blangero S","year":"2007","journal-title":"Am J Trop Med Hyg."},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86821989000300007"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.11.010"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.07.089"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0066-782X2001000100008"},{"key":"e_1_2_10_19_1","article-title":"Chagas heart disease: long term prognostic significance of nonsustained ventricular tachycardia and left ventricular dysfunction","volume":"22","author":"Rassi A","year":"1999","journal-title":"Pacing Clin Electrophysiol"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.75.6.1140"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.627323"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp357"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762009000900042"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1014204"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313122"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.019"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060301"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.12.017"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.05.033"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-7-21"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(97)00083-1"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0066-782X2006000400010"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.5935\/1678-9741.20140008"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050691f"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12342"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut422"},{"key":"e_1_2_10_37_1","first-page":"e350","article-title":"ACC\/AHA\/HRS 2008 Guidelines for device\u2010based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons","volume":"117","author":"Epstein A","year":"2008","journal-title":"Circulation."},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12013"},{"key":"e_1_2_10_39_1","article-title":"Chagasic cardiomyopathy is associated with increased morbidity and mortality compared with nonischemic cardiomyopathy among Latin American immigrants in Los Angeles","volume":"126","author":"Traina M","year":"2012","journal-title":"Circulation."}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.22421","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.22421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:15:32Z","timestamp":1696317332000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.22421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,21]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1002\/clc.22421"],"URL":"https:\/\/doi.org\/10.1002\/clc.22421","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,21]]}}}